CYP19A1 and breast carcinoma: In addition to glucocorticoids, several medications are known to increase hip fracture risk including thyroid hormone excess, aromatase inhibitors for the treatment of breast cancer and androgen deprivation for the treatment of prostate cancer [66–70]; (evidence level Ia).